| abstract |
The present invention relates to novel oxazolidinone compounds of the general formula (I) where R?1, R2, R3, Y1, Y1, Y2, Y3¿, and Z are as defined in the description; their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutical compositions containing them. |